In this study, a total of 963 cervical cancer samples and 178 non-cancer samples collected from in-house tissue microarrays and exterior microarrays and RNA-seq datasets were used for comprehensive assessment of the clinic-pathological significance of PLK1 in cervical cancer. Here, PLK1 is linked to cervical carcinoma.